We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Common Contracts

10 similar Securities Purchase Agreement contracts by Catalyst Pharmaceutical Partners, Inc., Oramed Pharmaceuticals Inc., Document Security Systems Inc, others

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • August 8th, 2024 • Rallybio Corp • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of April 10, 2024, by and among Rallybio Corporation, a Delaware corporation (the “Company”), and the purchaser identified on the signature pages hereto (including its successors and assigns, the “Purchaser”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • April 6th, 2023 • Oncocyte Corp • In vitro & in vivo diagnostic substances • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of April ___, 2023, and is between Oncocyte Corporation, a California corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • December 13th, 2021 • Star Equity Holdings, Inc. • Electromedical & electrotherapeutic apparatus • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of December 10, 2021, between Star Equity Holdings, Inc., a Delaware corporation (the “Company”), and the purchaser identified on the signature pages hereto (including his successors, heirs and assigns, the “Purchaser”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • June 13th, 2014 • Document Security Systems Inc • Services-computer integrated systems design • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of June 12, 2014, between Document Security Systems, Inc., a New York corporation (the “Company”), and the purchaser identified on the signature page hereto (including its successors and assigns, the “Purchaser”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • December 26th, 2013 • Oramed Pharmaceuticals Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of December 24, 2013, between Oramed Pharmaceuticals Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • July 11th, 2013 • Oramed Pharmaceuticals Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of July 10, 2013, between Oramed Pharmaceuticals Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • April 17th, 2012 • EnteroMedics Inc • Electromedical & electrotherapeutic apparatus • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of April 16, 2012, between EnteroMedics Inc., a Delaware corporation (the “Company”), and Kevin Douglas through his family trusts identified on Schedule A hereto (the “Purchaser”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • August 6th, 2010 • Catalyst Pharmaceutical Partners, Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of August 5, 2010, between Catalyst Pharmaceutical Partners, Inc., a Delaware corporation (the “Company”), and the party which executes the signature page attached hereto as purchaser (the “Purchaser”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • August 6th, 2010 • Catalyst Pharmaceutical Partners, Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of August 5, 2010, between Catalyst Pharmaceutical Partners, Inc., a Delaware corporation (the “Company”), and the party which executes the signature page attached hereto as purchaser (the “Purchaser”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • June 23rd, 2008 • Immunogen Inc • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of June 20, 2008, between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Ziff Asset Management, L.P., a Delaware limited partnership (the “Purchaser”).